Transforming clinical research by involving and empowering patients- the RATE-AF randomized trial.
作者信息
Bunting Karina V, Stanbury Mary, Tica Otilia, Kotecha Dipak
机构信息
Cardiac Physiologist & Postdoctoral Fellow, University of Birmingham & University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Lead for the Patient & Public Involvement Team, RATE-AF trial.
出版信息
Eur Heart J. 2021 Jul 1;42(25):2411-2414. doi: 10.1093/eurheartj/ehab098.
Abstract
摘要
相似文献
1
Transforming clinical research by involving and empowering patients- the RATE-AF randomized trial.通过让患者参与并赋予其权力来变革临床研究——RATE-AF随机试验
Eur Heart J. 2021 Jul 1;42(25):2411-2414. doi: 10.1093/eurheartj/ehab098.
2
Dronedarone for atrial fibrillation?决奈达隆用于治疗心房颤动？
Drug Ther Bull. 2010 Nov;48(11):126-8. doi: 10.1136/dtb.2010.11.0056.
3
Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.导管消融与抗心律失常药物治疗对心房颤动患者死亡率、卒中和出血及心搏骤停的影响：CABANA 随机临床试验。
JAMA. 2019 Apr 2;321(13):1261-1274. doi: 10.1001/jama.2019.0693.
4
Drug therapy for atrial fibrillation.心房颤动的药物治疗
Med Clin North Am. 2008 Jan;92(1):121-41, xi. doi: 10.1016/j.mcna.2007.08.002.
5
Randomized trial of rhythm or rate control in atrial fibrillation: the Pharmacological Intervention in Atrial Fibrillation Trial (PIAF).心房颤动节律控制与心率控制的随机试验：心房颤动药物干预试验（PIAF）
Eur Heart J. 2001 May;22(10):801-2. doi: 10.1053/euhj.2001.2596.
6
Progression of atrial fibrillation after a failed initial ablation procedure in patients with paroxysmal atrial fibrillation: a randomized comparison of drug therapy versus reablation.阵发性心房颤动患者初始消融失败后心房颤动的进展：药物治疗与再消融的随机比较。
Circ Arrhythm Electrophysiol. 2013 Aug;6(4):754-60. doi: 10.1161/CIRCEP.113.000495. Epub 2013 Jun 7.
7
Influence of sex on efficacy of exercise training for patients with symptomatic atrial fibrillation: insights from the ACTIVE-AF randomized controlled trial.性别对症状性心房颤动患者运动训练疗效的影响：来自 ACTIVE-AF 随机对照试验的观察。
Eur J Prev Cardiol. 2023 Dec 21;30(18):2006-2014. doi: 10.1093/eurjpc/zwad242.
8
Antiarrhythmic drugs management in patients with atrial fibrillation: the new guidelines.心房颤动患者的抗心律失常药物管理：新指南
Minerva Cardioangiol. 2011 Apr;59(2):187-95.
9
Drug therapy for termination of atrial fibrillation and maintenance of sinus rhythm.用于终止心房颤动并维持窦性心律的药物治疗。
Can J Cardiol. 2005 Sep;21 Suppl B:19B-25B.
10
Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.导管消融与药物治疗对心房颤动患者生活质量的影响：CABANA 随机临床试验。
JAMA. 2019 Apr 2;321(13):1275-1285. doi: 10.1001/jama.2019.0692.
引用本文的文献
1
Cost-effectiveness of digoxin versus beta blockers in permanent atrial fibrillation: the Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) randomised trial.地高辛与β受体阻滞剂治疗永久性心房颤动的成本效益：永久性心房颤动心率控制治疗评估（RATE-AF）随机试验
Heart. 2025 Mar 26;111(8):362-369. doi: 10.1136/heartjnl-2024-324761.
2
Consumer wearable devices for evaluation of heart rate control using digoxin versus beta-blockers: the RATE-AF randomized trial.使用地高辛与β受体阻滞剂评估心率控制的消费者可穿戴设备：RATE-AF 随机试验。
Nat Med. 2024 Jul;30(7):2030-2036. doi: 10.1038/s41591-024-03094-4. Epub 2024 Jul 15.
3
"Cardiac glycosides"-quo vaditis?-past, present, and future?“强心苷”——你们了解多少？——过去、现在和未来？
Naunyn Schmiedebergs Arch Pharmacol. 2024 Dec;397(12):9521-9531. doi: 10.1007/s00210-024-03285-3. Epub 2024 Jul 15.
4
Systematic approach to outcome assessment from coded electronic healthcare records in the DaRe2THINK NHS-embedded randomized trial.在DaRe2THINK NHS嵌入式随机试验中，从编码电子健康记录进行结果评估的系统方法。
Eur Heart J Digit Health. 2022 Sep 16;3(3):426-436. doi: 10.1093/ehjdh/ztac046. eCollection 2022 Sep.
5
Artificial intelligence to enhance clinical value across the spectrum of cardiovascular healthcare.人工智能提升心血管医疗保健全领域的临床价值。
Eur Heart J. 2023 Mar 1;44(9):713-725. doi: 10.1093/eurheartj/ehac758.
6
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research.临床研究中使用结构化电子健康记录的 CODE-EHR 最佳实践框架。
BMJ. 2022 Aug 29;378:e069048. doi: 10.1136/bmj-2021-069048.
7
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research.用于临床研究中使用结构化电子健康记录的 CODE-EHR 最佳实践框架。
Eur Heart J. 2022 Oct 7;43(37):3578-3588. doi: 10.1093/eurheartj/ehac426.
8
Post-mortem examination of high mortality in patients with heart failure and atrial fibrillation.心力衰竭合并心房颤动患者死亡率高的尸检研究。
BMC Med. 2022 Oct 5;20(1):331. doi: 10.1186/s12916-022-02533-8.
本文引用的文献
1
Consensus Statement on Public Involvement and Engagement with Data Intensive Health Research.关于公众参与和参与数据密集型健康研究的共识声明。
Int J Popul Data Sci. 2019 Feb 12;4(1):586. doi: 10.23889/ijpds.v4i1.586.
2
Improving the diagnosis of heart failure in patients with atrial fibrillation.改善心房颤动患者心力衰竭的诊断。
Heart. 2021 Jun;107(11):902-908. doi: 10.1136/heartjnl-2020-318557. Epub 2021 Mar 10.
3
Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial.地高辛与比索洛尔控制心房颤动患者心率对生活质量影响的比较：RATE-AF 随机临床试验。
JAMA. 2020 Dec 22;324(24):2497-2508. doi: 10.1001/jama.2020.23138.
4
Importance and Assessment of Quality of Life in Symptomatic Permanent Atrial Fibrillation: Patient Focus Groups from the RATE-AF Trial.症状性永久性心房颤动中生活质量的重要性和评估：来自 RATE-AF 试验的患者焦点小组。
Cardiology. 2020;145(10):666-675. doi: 10.1159/000511048. Epub 2020 Aug 28.
5
Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis.患者和公众参与对临床试验入组和保留的影响：系统评价和荟萃分析。
BMJ. 2018 Nov 28;363:k4738. doi: 10.1136/bmj.k4738.
6
Assessing the Financial Value of Patient Engagement: A Quantitative Approach from CTTI's Patient Groups and Clinical Trials Project.评估患者参与的财务价值：来自CTTI患者群体与临床试验项目的定量方法。
Ther Innov Regul Sci. 2018 Mar;52(2):220-229. doi: 10.1177/2168479017716715. Epub 2017 Jul 17.
7
A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial.心房颤动心率控制综述以及RATE-AF试验的基本原理和方案。
BMJ Open. 2017 Jul 20;7(7):e015099. doi: 10.1136/bmjopen-2016-015099.
8
Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data.地高辛的安全性和有效性：观察性和对照试验数据的系统评价与荟萃分析
BMJ. 2015 Aug 30;351:h4451. doi: 10.1136/bmj.h4451.
Zotero 插件